Papers

1

Total Citations

6

H-Index

1

About

Raffaella Gaggeri is a pharmaceutical scientist whose research centers on the physicochemical stability of intravenous drug formulations, with a particular focus on oncology therapeutics. Her most cited work investigates the stability of calcium levofolinate (CaLev), a critical chemotherapy adjuvant, when reconstituted and stored in polyolefin/polyamide infusion bags with NaCl 0.9% and glucose 5% solutions. This study, garnering 6 citations, addresses a pressing clinical need: the lack of stability data for CaLev solutions, which previously necessitated extemporaneous manual preparation. By establishing evidence-based storage parameters, Gaggeri’s work enables safer, more efficient preparation protocols, reducing waste and improving patient access to consistent dosing. Her contributions exemplify the intersection of pharmaceutical chemistry and clinical practice, offering practical solutions for hospital pharmacies. While her citation count reflects the niche yet vital nature of her research, the impact is substantial within the field of drug stability and compounding. Gaggeri’s dedication to rigorous stability testing underscores her role in advancing the reliability of intravenous therapies, directly supporting healthcare professionals in delivering precise, safe treatments.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/polyamide infusion bags
6 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago